iShares Dow Jones US Pharmaceuticals Index Fund (IHE)
- Equity | Health/Biotechnology Funds
- Loading...
Best Fit Health/Biotechnology Funds ETFs
U.S. News evaluated 29 Health/Biotechnology Funds ETFs and 14 make our Best Fit list. Our list highlights the best passively managed funds for long-term investors. Rankings are assigned based on comparisons with Best Fit funds in this category.
| Best Fit Scorecard | |
|---|---|
| Costs | Good |
| Tracking Error | Good |
| Bid/Ask Ratio | Good |
| Holdings Diversity | Typical |
Fund Description
The investment seeks to replicate the Dow Jones U.S. Select Pharmaceuticals Index (the "underlying index"). The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. Components primarily include health care and pharmaceuticals companies. The fund is non-diversified.
Fund Snapshot Updated 05.23.2013
| Previous Close | $102.80 | Expense Ratio | 0.48% |
| YTD Return | 21.3% | Avg. 30-Day Volume | 55,292 |
| 1-Year Return | 28.0% | Market Cap | Loading... |
| Bid | $102.74 | Shares Outstanding | 4,550,000 |
| Ask | $102.77 | Dividends | $1.67 |
| Top 10 Holdings | |
|---|---|
| Johnson & Johnson (JNJ) | 9.99% |
| Pfizer Inc (PFE) | 8.91% |
| Merck & Co Inc New (MRK) | 7.98% |
| Bristol Myers Squibb Co (BMY) | 7.00% |
| Abbott Labs (ABT) | 5.76% |
| Lilly Eli & Co (LLY) | 5.28% |
| Actavis Inc (ACT) | 4.50% |
| Allergan Inc (AGN) | 3.95% |
| Mylan Inc (MYL) | 3.27% |
| Perrigo Co (PRGO) | 3.00% |
| % of Total Holdings | 59.60% |
